MedTrace Logo

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain

NCT04637529 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2023-07-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of S (+) - ibuprofen compared to an active treatment for pain control in individuals diagnosed with osteoarthritis.

Conditions

Interventions

DRUG

S (+) - Ibuprofen

S (+) - Ibuprofen + placebo of Ibuvix®

DRUG

Ibuvix® - ibuprofen

Ibuvix® + placebo of S(+) - Ibuprofen

Sponsors & Collaborators

  • Apsen Farmaceutica S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-05
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04637529 on ClinicalTrials.gov